Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aveanna Healthcare HoldingsAVAH -3.03%63 EV-to-EBITDA is 11.16 as of Jul. 22, 2026, which is 9% below its 10-year median of 12.23. GuruFocus rates AVAH with a GF Score™ of 63/100 and a GF Value™ of $5.18 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 506 Healthcare Providers & Services companies, Aveanna Healthcare Holdings ranks worse than 51.98% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Aveanna Healthcare Holdings's enterprise value is $3,366 Mil.
Aveanna Healthcare Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $302 Mil. Therefore, Aveanna Healthcare Holdings's EV-to-EBITDA for today is 11.16.
The historical rank and industry rank for Aveanna Healthcare Holdings's EV-to-EBITDA or its related term are showing as below:
AVAH'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -188.75 Med: 12.23 Max: 223.2
Current: 11.16
During the past 8 years, the highest EV-to-EBITDA of Aveanna Healthcare Holdings was 223.20. The lowest was -188.75. And the median was 12.23.
AVAH's EV-to-EBITDA is ranked worse than 51.98% of 506
companies
in the Healthcare Providers & Services industry
Industry Median: 11.075
vs AVAH: 11.16
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Aveanna Healthcare Holdings's PE Ratio (TTM) for today is calculated as:
Aveanna Healthcare Holdings's share price for today is $9.43.
Aveanna Healthcare Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.180.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Aveanna Healthcare Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aveanna Healthcare Holdings EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aveanna Healthcare Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Aveanna Healthcare Holdings's EV-to-EBITDA falls into.
Aveanna Healthcare Holdings's current Enterprise Value is $3,366 Mil.
Aveanna Healthcare Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $302 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aveanna Healthcare Holdings (AVAH) has a EV-to-EBITDA of 11.16 as of Jul. 22, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Aveanna Healthcare Holdings. This is near median its historical median of 12.23. According to the industry distribution chart, Aveanna Healthcare Holdings ranks #263 out of 506 companies in the Healthcare Providers & Services industry, placing it in the top 52%.
Is Aveanna Healthcare Holdings' EV-to-EBITDA too high?
Aveanna Healthcare Holdings' current EV-to-EBITDA of 11.16 is near median its 10-year median of 12.23. The Healthcare Providers & Services industry median EV-to-EBITDA is 11.08. Aveanna Healthcare Holdings' value of 11.16 is 0.8% above this industry median. Based on the distribution chart, Aveanna Healthcare Holdings ranks #263 out of 506 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Aveanna Healthcare Holdings has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aveanna Healthcare Holdings' EV-to-EBITDA compare to SNDA and ADUS?
According to the Healthcare Providers & Services industry distribution chart, Aveanna Healthcare Holdings ranks #263 out of 506 companies for EV-to-EBITDA. This places Aveanna Healthcare Holdings in the lower half of its industry. The industry median EV-to-EBITDA is 11.08. Aveanna Healthcare Holdings' value of 11.16 is 0.8% above this benchmark. While the company's 10-year median is 12.23 vs. the industry median of 11.08, Aveanna Healthcare Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.08, based on 506 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aveanna Healthcare Holdings's current EV-to-EBITDA of 11.16 is 0.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Aveanna Healthcare Holdings. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aveanna Healthcare Holdings's current EV-to-EBITDA is 11.16, which is near median its own 10-year median of 12.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aveanna Healthcare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Aveanna Healthcare Holdings (AVAH) is currently considered Significantly Overvalued. The stock's GF Value™ is $5.18, compared to a current price of $9.43 — trading 82% above its estimated fair value. The current EV-to-EBITDA is 11.16, which is near median its 10-year median of 12.23 and 0.8% above the Healthcare Providers & Services industry median of 11.08. Aveanna Healthcare Holdings' overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Aveanna Healthcare Holdings (AVAH), the current EV-to-EBITDA is 11.16 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aveanna Healthcare Holdings (AVAH) Overvalued in 2026?
Based on GuruFocus' analysis, Aveanna Healthcare Holdings stock appears to be overvalued.
The current stock price of $9.43 is trading 82% above its estimated GF Value™ of $5.18.
GuruFocus considers Aveanna Healthcare Holdings to be Significantly Overvalued.
Key valuation signals for AVAH:
EV-to-EBITDA: 11.16 (near median its 10-year median of 12.23)
GF Value™: $5.18 vs. price of $9.43 (82% above fair value)
Industry Position: 0.8% above the Healthcare Providers & Services median (#263 of 506)
No single metric tells the full story. See the AVAH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.
63GF Score
Get the complete analysis for AVAH
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVAH has been successfully added to your 
